ClinVar Miner

Submissions for variant NM_001127222.2(CACNA1A):c.5414_5415del (p.Phe1805fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center RCV004785168 SCV005397752 likely pathogenic Spinocerebellar ataxia type 6 2024-01-26 criteria provided, single submitter clinical testing This sequence variant is a two-nucleotide deletion (delTT) in exon 36 of 47 of the CACNA1A gene and results in an early termination signal 9 amino acids downstream of the frameshift at the Phe1805 codon. This variant is predicted to generate a non-functional allele through either the expression of a truncated protein or a loss of calcium voltage-gated channel subunit alpha1 A expression due to nonsense mediated decay. This variant is absent from ClinVar and has not been observed in an individual affected by a CACNA1A-related disorder in the published literature, to our knowledge. This variant is present in the from the gnomAD v4.0.0 population database (1 of 833,090 alleles, 0.0001%). Studies examining the functional consequence of this variant have not been published, to our knowledge. Haploinsufficiency in CACNA1A is a known mechanism of disease (PMID: 33737904). Based upon the evidence, we consider this variant to be likely pathogenic. ACMG Criteria: PM2, PVS1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.